The most commonly mutated spliceosome genes in myeloid malignancies, SF3B1, SRSF2, and U2AF1, are also frequently identified in individuals with CHIP (Genovese et al., 2014; Jaiswal et al., 2014). This evidence concerns the gene U2AF1 and myeloid neoplasm.